
Tilray Gets Bullish Call on 40% Upside, But Headwinds Persist
Roth Capital upgrades $TLRY to buy with $10 target, citing international growth and beverage strength. Skeptics note missed revenues and cannabis sector challenges.
TLRYanalyst upgradeinternational expansion